Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

No evidence of increased risk for certain highly atherogenic lipoprotein phenotypes in HIV-infected patients.

Archives of medical research - 1 Jan 2008

Catzin-Kuhlmann Andrés, Castillo-Martínez Lilia, Colín-Ramírez Eloisa, Valles Victoria, Aguilar-Salinas Carlos A, Sierra Juan, Calva Juan J

Abstract excerpt

BACKGROUND: There is a need to assess whether human immunodeficiency virus (HIV)-infected patients are more likely than noninfected individuals to have any of the specific lipoprotein combination profiles identified as the best predictors of future cardiovascular disease in the general population. METHODS: One hundred five infected patients, randomly selected from a Mexican HIV clinic, and 105 age- and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-HIV Agents
Share to Apolipoprotein A-I

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Apolipoproteins B

Share to Atherosclerosis

Share to HIV Infections

Share to Hypertriglyceridemia

Share to Mexico

Source

Identifiers

PMID: 18068000
DOI: 10.1016/j.arcmed.2007.06.012

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

No evidence of increased risk for certain highly atherogenic lipoprotein phenotypes in HIV-infected patients.PMID 18068000Read ↗

Dyslipidemia in HIV-infected individuals: from pharmacogenetics to pharmacogenomics.Semantic proximity Read ↗

Pharmacogenetics of the metabolic disturbances and atherosclerosis associated with antiretroviral therapy in HIV-infected patients.Semantic proximity Read ↗

Genetic architecture of cardiometabolic risks in people living with HIVSemantic proximity Read ↗

Polymorphisms in LPL, CETP, and HL protect HIV-infected patients from atherogenic dyslipidemia in an allele-dose-dependent manner.Semantic proximity Read ↗

Metabolic syndrome in human immunodeficiency virus-positive subjects: prevalence, phenotype, and related alterations in arterial structure and function.Semantic proximity Read ↗

Prevalence of Selected Cardiometabolic Risk Factors in The Global ART-Naïve HIV Infected Population: A Protocol for a Systematic Review and Meta-AnalysisSemantic proximity Read ↗

Contribution of genome-wide significant single-nucleotide polymorphisms and antiretroviral therapy to dyslipidemia in HIV-infected individuals: a longitudinal study.Semantic proximity Read ↗

HIV-specific immune dysregulation and atherosclerosis.Semantic proximity Read ↗

Lipoprotein(a) and HIV: Allele-Specific Apolipoprotein(a) Levels Predict Carotid Intima-Media Thickness in HIV-Infected Young Women in the Women's Interagency HIV Study.Semantic proximity Read ↗

Association between polymorphisms in genes involved in lipid metabolism and immunological status in chronically HIV-infected patients.Semantic proximity Read ↗

Association of Single Nucleotide Polymorphisms with Dyslipidemia in Antiretroviral Exposed HIV Patients in a Ghanaian populationSemantic proximity Read ↗

High frequency of Fredrickson's phenotypes IV and IIb in Brazilians infected by human immunodeficiency virus.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.